Iterum Therapeutics Announces Topline Results from Phase 3 Clinical Trial of Oral and IV Sulopenem for the Treatment of Complicated Intra-abdominal Infections

Paul Theisen
Patient Acquisition

David Linetsky
Point-of-Care Marketing

Daniel Sontupe
Market Access

Stacey Gandler
Brand Nourishment

Suma Ramadas, PhD
Medical Affairs

Pat Purcell
Meeting Engagement

Matt Turner
Patient Affordability

Joey Cohen
Medication Adherence

Frank Burrell
Scientific Storytelling

Amy Giles
Increasing Engagement

Liz Kane
Impactful Strategy

Brenda Snow
Authentic Patient Voice

Bud Bilanich
Success Coach

Matthew Durham
Omnidynamic Marketing